Contact us for free information or to start a free case review.
Multaq® (dronedarone) is a medication for people with the recurrent conditions atrial fibrillation and atrial flutter to help regulate their heartbeat and keep them out of the hospital. Patients take the drug at a time when the heart beat is normal to reduce the occurrences of either condition or before they go to the hospital to have a medical treatment to return the heart to a normal rhythm.
In patients with atrial fibrillation, the heart beats irregularly and too quickly. Atrial flutter describes the heart that beats regularly but is beating too fast. Atrial fibrillation is a common heart condition, affecting 2.5 million Americans.
The medication received approval from the U.S. Food and Drug Administration (FDA) on July 1, 2009. Since its approval, it has been linked with 387 reports of adverse effects, including 24 deaths.
Multaq® can be harmful when taken with many other drugs. There are 422 other drugs that are known to have harmful interactions with Multaq: a total of 229 drugs that have major (very serious) interactions with Multaq, 189 that have moderate interactions with Multaq®, and four drugs that have minor interactions with the heart medication.
Common medications that are known to have serious major interactions with Multaq® include:
The following drugs are among those that have moderate drug interactions:
Other drugs Multaq® may interact with are:
Foods known to interfere with Multaq® are grapefruit and grapefruit juice. Through biochemical interactions, they can increase the amount of the drug in plasma.
The medication carries a black box warning (the most serious warning required by the FDA) on its label that it should not be taken by patients with severe heart failure, for it can cause death. Patients who become short of breath while resting, after a small amount of exercise, or after any physical activity should tell their doctors before starting Multaq®.
Contact a Multaq® attorney if you believe you’ve been harmed by the medication. You may qualify to seek compensation for your injuries. For a case evaluation, contact our Multaq® attorneys today.
The FDA notified healthcare professionals about new findings that link Multaq® to severe liver injuries, Jan. 14, 2011. The agency said there were two report...
Copyright © 2001 - 2012 Online Lawyer Source | Legal Marketing Site Designed by eJustice
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.